# RELAXaHEAD for Headache Patients (Phase II)

> **NCT05466682** · NA · COMPLETED · sponsor: **NYU Langone Health** · enrollment: 48 (actual)

## Conditions studied

- Migraine
- Headache
- Multiple Sclerosis
- Insomnia

## Interventions

- **BEHAVIORAL:** Smartphone-Based Progressive Muscle Relaxation Therapy (PMR)
- **BEHAVIORAL:** Monitored Usual Care (MUC)

## Key facts

- **NCT ID:** NCT05466682
- **Lead sponsor:** NYU Langone Health
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-06-09
- **Primary completion:** 2022-12-19
- **Final completion:** 2023-06-19
- **Target enrollment:** 48 (ACTUAL)
- **Last updated:** 2024-01-10

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05466682

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05466682, "RELAXaHEAD for Headache Patients (Phase II)". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT05466682. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*